Matthew Wiley
Corporate Officer/Principal chez BIOXCEL THERAPEUTICS, INC.
Fortune : 5 199 $ au 30/04/2024
Provenance du réseau au premier degré de Matthew Wiley
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA.
22
| Subsidiary | Pharmaceuticals: Major | 22 |
| Public Company | Biotechnology | 15 | |
VYNE Pharmaceuticals Ltd.
 VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
Jazz Pharmaceuticals Commercial Corp.
 Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals Commercial Corp. provides pharmaceutical services. It engages in identifying, developing, and commercializing products in the areas of CNS, women's health, and urology. The company was founded in 2005 and is headquartered in Philadelphia, PA.
4
| Extinct | Pharmaceuticals: Major | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Matthew Wiley via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Sales & Marketing General Counsel | |
| ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing General Counsel Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal | |
| GIVEN IMAGING LTD. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
| AMYRIS, INC. | Chemicals: Specialty | Corporate Officer/Principal General Counsel | |
| NGM BIOPHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Compliance Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
The Governor & Company of the Bank of Ireland
 The Governor & Company of the Bank of Ireland Major BanksFinance Bank of Ireland provides banking and financial services. It operates through the following segments: Retail Ireland, Bank of Ireland Life, Retail UK, Corporate & Treasury and Group Centre and Other. The Retail Ireland segment offers a comprehensive range of banking products and related financial services to the personal and business markets including deposits, mortgages, consumer and business lending, credit cards, current accounts, money transmission services, commercial finance, asset finance and general insurance. It serves customers through a distribution network of branches, central support teams, ATMs and through direct channels. The Bank of Ireland Life segment includes the wholly owned subsidiary, New Ireland Assurance Co., through which the group offers a wide range of pension and life products, including life assurance, life protection, pensions and investment products to the Irish market. The Retail UK segment comprises consumer and business banking via a branch network in Northern Ireland, its UK residential mortgage business, and the business partnerships with the UK Post Office. The Corporate & Treasury segment comprises the group's corporate banking and global markets activities across the Republic of Ireland, UK and international jurisdictions. The Group Centre and Other segment is responsible for delivering services to each division and includes group manufacturing, group finance, group credit and market risk, group governance risk, and group human resources. The company was founded in 1783 and is headquartered in Dublin, Ireland. | Major Banks | Director/Board Member | |
Reckitt Benckiser Healthcare International Ltd.
 Reckitt Benckiser Healthcare International Ltd. Household/Personal CareConsumer Non-Durables Reckitt Benckiser Healthcare International Ltd. manufactures healthcare and beauty products. The company develops & markets analgesics, upper respiratory tract and skincare products. It is headquartered in Nottingham, the United Kingdom. | Household/Personal Care | Chief Executive Officer | |
Yissum Research Development Co. Ltd.
 Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | Investment Managers | Chairman | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree | |
| Syracuse University | College/University | Undergraduate Degree Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
| University College Dublin | College/University | Graduate Degree Undergraduate Degree | |
| Trinity College Dublin | College/University | Graduate Degree Graduate Degree | |
| Technion-Israel Institute of Technology | College/University | Graduate Degree | |
| The Hebrew University of Jerusalem | College/University | Doctorate Degree | |
TransPharma Medical Ltd.
 TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities. | Pharmaceuticals: Major | Director/Board Member | |
| PROTALIX BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Biotechnology | Chairman | |
Leo Pharma, Inc.
 Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Drugstore Chains | Sales & Marketing Corporate Officer/Principal | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
BioMAS Ltd.
 BioMAS Ltd. Pharmaceuticals: MajorHealth Technology BioMAS Ltd. is an Israeli pharmaceutical company that was founded in 2000. The private company is based in Jerusalem, Israel and develops drugs that are based on tellurium. | Pharmaceuticals: Major | Chairman | |
| Amorphical Ltd. | Chairman | ||
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Director of Finance/CFO Director/Board Member Director/Board Member President General Counsel General Counsel Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member Corporate Officer/Principal Sales & Marketing Director/Board Member | |
| Berlex Laboratories, Inc. | General Counsel General Counsel | ||
| AXCA HEALPAR | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Harvard Law School | College/University | Graduate Degree Graduate Degree | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
Emergent BioSolutions Ireland Ltd.
 Emergent BioSolutions Ireland Ltd. Pharmaceuticals: MajorHealth Technology Adapt Pharma Ltd. develops and distributes therapeutic treatments. The company was founded by David Brabazon and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Chief Operating Officer | |
| QUINCE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| UNIPHAR PLC | Medical Distributors | Director/Board Member | |
| Medingalil Ltd. | Director/Board Member | ||
BioXcel Corp.
 BioXcel Corp. Data Processing ServicesTechnology Services BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation. | Data Processing Services | Director/Board Member Chief Executive Officer Founder Corporate Officer/Principal | |
| 9 METERS BIOPHARMA, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
Ergonomic Solutions Ltd.
 Ergonomic Solutions Ltd. Electronics DistributorsDistribution Services Ergonomic Solutions Ltd. is a private company based in Epsom, UK. and has subsidiaries in Italy. The British company was founded in 1996 and is led by CEO Ian Campbell Dewar. | Electronics Distributors | Director/Board Member | |
Crookes Healthcare Ltd. (Ireland)
 Crookes Healthcare Ltd. (Ireland) Medical/Nursing ServicesHealth Services Crookes Healthcare Ltd. (Ireland), a subsidiary of Reckitt Benckiser Group Plc, is a company headquartered in Dublin, Ireland. The firm provides other human health services. | Medical/Nursing Services | Corporate Officer/Principal | |
| VYNE THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer General Counsel Director/Board Member | |
Invea Therapeutics, Inc.
 Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer |
Statistiques
Internationale
| Etats-Unis | 28 |
| Israël | 12 |
| Irlande | 10 |
| Royaume-Uni | 4 |
Sectorielle
| Health Technology | 27 |
| Consumer Services | 11 |
| Finance | 3 |
| Distribution Services | 3 |
| Commercial Services | 2 |
Opérationnelle
| Director/Board Member | 265 |
| Corporate Officer/Principal | 139 |
| Independent Dir/Board Member | 86 |
| Chairman | 49 |
| Undergraduate Degree | 43 |
Relations les plus connectées
| Insiders | |
|---|---|
| Elmar Schnee | 31 |
| Samuel D. Colella | 31 |
| Kathryn Falberg | 30 |
| Aharon Schwartz | 29 |
| Norbert Riedel | 29 |
| Catherine Sohn | 27 |
| Rex Bright | 24 |
| Stanley Stern | 23 |
| Bryan Cressey | 21 |
| Dalia Megiddo | 18 |
| Michael Michelson | 18 |
| Heather McSharry | 15 |
| Elena Viboch | 14 |
| Sandeep Laumas | 14 |
| Peter Mueller | 14 |
- Bourse
- Insiders
- Matthew Wiley
- Connexions Sociétés
